The Liver King Lie: Misrepresentation, justification, and public health implications.
Cognitive dissonance
Performance and image enhancing drugs
Public health
Social identity
Steroids
Techniques of neutralization
Journal
The International journal on drug policy
ISSN: 1873-4758
Titre abrégé: Int J Drug Policy
Pays: Netherlands
ID NLM: 9014759
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
20
12
2022
revised:
23
01
2023
accepted:
13
02
2023
medline:
28
3
2023
pubmed:
26
2
2023
entrez:
25
2
2023
Statut:
ppublish
Résumé
It is well-established that performance and image enhancing drugs (PIEDs) are effective in increasing muscle mass and strength. PIEDs are unique in that, while harm may result from use, there is little evidence of widespread individual or social harm comparable with other illicit substances. However, given the rapid growth of the online health and fitness industry, the digital consumption of hardcore fitness content represents a space ripe for indirect harms. A poignant example of this trend among the digital health and fitness community is the contestation around 'fake natty' users, who falsely claim to not use PIEDs. The non-disclosure of use has the potential to give individuals who are not enhanced the false impression that they too can achieve a bodily ideal which is similar, potentially resulting in psychological distress and risky behaviours. In this commentary, we discuss this harmful phenomenon using the case study of the fitness influencer Brian Johnson, more commonly known as Liver King. Employing a psycho-criminological lens, we use Social Identity Theories to understand the 'Primal' identity, before unpacking Johnson's disavowal of his PIED consumption through Sykes and Matza's (1957) techniques of neutralization. We conclude with an overview of the harms surrounding fake natural influencers and cognitive dissonance, before attempting to map a path towards emic harm reduction in collaboration with the digital fitness community.
Identifiants
pubmed: 36841216
pii: S0955-3959(23)00028-2
doi: 10.1016/j.drugpo.2023.103979
pii:
doi:
Substances chimiques
Performance-Enhancing Substances
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103979Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declarations of Interest The Authors declare that there is no conflict of interest.